EpiPen Maker Must Pay $465 Million to Settle Lawsuit
Summary: Mylan has agreed to pay $465 million after misclassifying the Epipen as generic and therefore avoiding Medicaid payments. Last…
EpiPen
Mylan Investigated for Antitrust Violations
Summary: After increasing the price of EpiPens so that they are no longer affordable, drugmaker Mylan is being investigated for…
EpiPen CEO Tied to Democratic Senator
Summary: The CEO responsible for the manufacturing and overwhelming steep increase in cost of EpiPens is the daughter of Democratic…